Natalizumab subcutaneous injection for the treatment of relapsing multiple sclerosis patients: A new delivery route

Mult Scler Relat Disord. 2021 Oct:55:103179. doi: 10.1016/j.msard.2021.103179. Epub 2021 Jul 27.

¹ Neuroimmunology Unit, Department of Neuroscience, Hospital Alem´an, Buenos Aires, Argentina. Electronic address: pabloLopez@hospitalaleman.com.
² Neurology Department, Centro Universitario de Esclerosis Múltiple (CUEM), J.M. Ramos Mejía Hospital, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
³ Neuroimmunology Unit, Department of Neuroscience, Hospital Alem´an, Buenos Aires, Argentina. Electronic address: ecarnerocontentti@hospitalaleman.com.

No abstract available

MeSH terms